Who can have sotrovimab

Sotrovimab can be given to most adults, and children aged 12 years or older who weigh at least 40kg.

You may be eligible for sotrovimab if:

you're in the highest risk group below
you've tested positive for COVID-19 – find out about COVID-19 rapid lateral flow test
you have had COVID-19 symptoms within the last 5 days

Show people at highest risk

You may be at highest risk of getting seriously ill from COVID-19 if you:

have Down's syndrome, or another chromosomal condition that affects your immune system
have certain types of cancer, or had treatment for certain types of cancer
have sickle cell disease
have certain conditions affecting your blood, including some types of blood cancer
have chronic kidney disease (CKD) stage 4 or 5, including people on dialysis
have severe liver disease
have had an organ transplant or are on the organ transplant waiting list
have certain autoimmune or inflammatory conditions, such as rheumatoid arthritis or inflammatory bowel disease
have HIV or AIDS and have a weakened immune system
have a condition affecting your immune system
have a condition affecting the brain or nervous system, such as multiple sclerosis, muscular dystrophy, motor neurone disease, myasthenia gravis, Huntington's disease, Parkinson's disease or certain types of dementia
have certain lung conditions or treatments for lung conditions

This list is a summary and does not cover everything.

If you're unsure if you are eligible, speak to your GP or hospital specialist who can advise you.

Who may not be able to have sotrovimab

Sotrovimab is not suitable for some people. To make sure it's safe for you, tell your doctor or nurse if: